FDA Approves ImmGolis for Accord BioPharma: First Interchangeable Simponi Biosimilar Enters U.S. Market
Accord BioPharma and Bio-Thera Solutions achieve a historic FDA approval for ImmGolis, the first interchangeable simponi biosimilar to reach the U.S. market.
